Most recently, research efforts have demonstrated that patients with psoriasis have increased expression of the NLRP3 inflammasome in plasma, along with caspase-1 reactivity and elevated inflammasome-generated IL-1β and IL-18 concentrations [16]. This evidence concerns the gene NLRP3 and psoriasis.